Position in PAHC
as of Mar 31, 2026
· filed Apr 22, 2026
Position Value
$237,833
+$92,129 QoQ
Shares Held
4,300
+10.3% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Common Shares in PAHC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Spire Wealth Management holds $860,691 across 13 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
6,254 | $449,412 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
690 | $116,292 | |
| 3 | 17,767 | $56,143 | |||
| 4 | COLL |
Collegium Pharmaceutical, Inc
|
1,301 | $47,096 | |
| 5 | HLN |
Haleon plc
|
4,358 | $40,660 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
59 | $31,967 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
792 | $26,832 | |
| 8 | VTRS |
Viatris Inc
|
1,591 | $25,265 |
All Filings in PAHC
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $237,833 | 4,300 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $145,704 | 3,900 | Shares | Sole | 2026-01-14 | |
| No filing history on record for this holder in this stock. | ||||||